Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Synthetic Hormones Market?

In the last few years, the synthetic hormones market has seen substantial growth. The market size is projected to increase from $6.38 billion in 2024 to $6.71 billion in 2025, showing a compound annual growth rate (CAGR) of 5.1%. The past growth can be linked to factors such as animal growth enhancement, performance improvement, environmental impact, fertility therapies, and management of menopausal symptoms.

The market for synthetic hormones is projected to experience a consistent expansion in the upcoming years, reaching “$7.98 billion in 2029”, with a Compound Annual Growth Rate (CAGR) of 4.4%. This projected growth within the forecast period is largely due to the increasing expansion of the transgender healthcare market, escalating healthcare expenses and insurance coverage, established regulatory approvals, and the widening application scope of synthetic hormones. Noteworthy trends expected over the forecast period incorporate the popularity of plant-based hormone therapy, the incorporation of hormone therapy in anti-aging regimens, advancements in technology for drug delivery, as well as an increased focus on hormone-free methods of birth control.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Growth Drivers Are Shaping The Synthetic Hormones Market Outlook?

Rising cases of hormonal imbalances are anticipated to fuel the expansion of the synthetic hormones market in the future. Hormonal imbalance, characterized by having excessive or insufficient levels of a hormone in the bloodstream, can stem from stress, aging, medical issues, or lifestyle habits, interfering with the body’s normal production and control of hormones. Synthetic hormones serve to supplement or substitute natural hormones when hormonal imbalances occur, helping to govern physical functions and mitigate symptoms linked to deficiencies or surpluses. For example, data from the NHS Business Services Authority, a non-departmental public body in the UK, indicates that around 7.80 million hormone replacement therapy (HRT) items were prescribed in England in 2022, signifying a 35.0% rise from the previous year. Hence, the escalating prevalence of hormonal imbalances is propelling the expansion of the synthetic hormones market.

How Is The Synthetic Hormones Market Organized By Different Segments?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What Current And Upcoming Trends Are Shaping The Synthetic Hormones Market?

Leading businesses in the synthetic hormone market are prioritizing the development of novel products, such as the recombinant human growth hormone, to boost their market profitability. The recombinant human growth hormone is a man-made hormone used in the treatment of growth hormone deficiencies in both children and adults, as well as some medical conditions associated with this deficiency. For example, Pfizer Inc., an American pharmaceutical company, and OPKO Health Inc., an American medical testing and medication enterprise, got approval in February 2022 to market once-weekly NGENLA (somatrogon) injections in the European Union. These injections are designed to address pediatric growth hormone deficiency in children and adolescents aged three years and above. This new long-lasting injection offers an option for individuals suffering from growth disorders due to inadequate growth hormone production. NGENLA is delivered through subcutaneous injection and remains in the system longer than daily growth hormone injections, thus requiring only once-a-week administration.

Who Are The Most Influential Companies In The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Dominates The Synthetic Hormones Market Today?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model